Werfen is chaired by Marc Rubiralta and in 2022 it achieved a turnover of 1.84 billion. In the largest operation in its history, the group closed...
Genesis Biomed's position in Valencia is backed by its experience in the field of technology transfer and early-stage biomedical projects in the region, having worked for universities (UPV, UV,...
Ship2B launched its first investment vehicle in 2016, with €4.5 million, investing in 23 companies of which they have already divested from three companies. In 2020, the...
AstraZeneca’s commitment to the Spanish territory can also be seen in the creation of infrastructure since it has allocated a total of €5.5 million for the...
In detail, this new financing was led by Sofinnova Partners and co-managed by Intermediate Capital Group, but the transaction also benefited from the participation of historical...
In addition to the factory expansion project, iVascular estimates that over the next five years it will allocate €40 million to investments in research, development, and...
Angelini Industries had already focused on innovation, particularly in Indusriy 4.0, by investing in the Forward Factory accelerator launched by Cdp Venture Capital sgr. Forward Factory...